Steven Pfanstiel - Jan 18, 2024 Form 4 Insider Report for MARINUS PHARMACEUTICALS, INC. (MRNS)

Signature
/s/ Debra A. Mohollen, Attorney-in-Fact
Stock symbol
MRNS
Transactions as of
Jan 18, 2024
Transactions value $
$0
Form type
4
Date filed
1/19/2024, 04:19 PM
Previous filing
Aug 8, 2023
Next filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNS Common Stock Award $0 +25.5K +51.63% $0.00 74.8K Jan 18, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNS Stock Option (Right to Buy) Award $0 +115K $0.00 115K Jan 18, 2024 Common Stock 115K $9.74 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of restricted stock units (RSUs). The RSUs vest in three equal installments, with the first installment vesting on February 15, 2025, the second installment vesting on February 15, 2026, and the third installment vesting on February 15, 2027, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
F2 The option vests and becomes exercisable in 36 equal monthly installments beginning on February 18, 2024, subject to the reporting person's continued service with the Issuer.